Effects of tryprostatin derivatives on microtubule assembly in vitro and in situ

Journal of Antibiotics

Volumn 51, Issue 8, 1998, Pages 801-804

  Kondoh, Masuo ^a,b,c   Usui, Takeo ^a   Mayumi, Tadanori ^b   Osada, Hiroyuki ^a  

^a INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMITOTIC AGENT; COLCHICINE; TRYPROSTATIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; MICROTUBULE ASSEMBLY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031687689     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.51.801     Document Type: Article

References (16)

1. CORREIA, J. J.: Effects of antimitotic agents on tubulin-nucleotide interaction. Pharmacol. Ther. 52: 127-147, 1991
2. DESAI, A. & T. J. MITCHISON: Microtubule polymerization dynamics. Annu. Rev. Cell Dev. Biol. 13: 83-117, 1997
3. GARLAND, D. L.: Kinetics and mechanism of colchicine binding to tubulin: evidence for ligand-induced conformational change. Biochemistry 17: 4266-4272, 1978
4. HIMES, R. H.; R. N. KERSEY, I. HELLER-BETTINGER & F. E. SAMSON: Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro. Cancer Res. 36: 3798-3802, 1976
5. TAKAHASHI, M.; S. IWASAKI, H. KOBAYASHI, S. OKUDA, T. MURAI, Y. SATO, T. HARAGUCHI-HIRAOKA & H. NAGANO: Studies on macrocyclic lactone antibiotics XI. Anti-mitotic and anti-tubulin activity of new antitumor antibiotics, rhizoxin and its homologues. J. Antibiotics 40: 66-72, 1987
6. BAI, R.; R. E. SCHWARTZ, J. A. KEPLER, G. R. PETTIT & E. HAMEL: Characterization of the interaction of cryptophycin 1 with tubulin: binding in the vinca domain, competitive inhibition of dolastatin 10 binding, and an unusual aggregation reaction. Cancer Res. 56: 4398-4406, 1996
7. SCHIFF, P. B.; J. FANT & S. B. HORWITZ: Promotion of microtubule assembly in vitro by taxol. Nature 277: 665-667, 1979
8. BOLLAG, D. M.; P. A. MCQUENEY, J. ZHU, O. HENSENS, L. KOUPAL, J. LIESCH, M. GOETZ, E. LAZARIDES & C. M. WOODS: Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. Cancer Res. 55: 2325-2333, 1995
9. NICOLAOU, K. C.; N. WINSSINGER, J. PASTOR, S. NINKOVIC, F. SARABIA, Y. HE, D. VOURLOUMIS, Z. YANG, T. LI, P. GIANNAKAKOU & E. HAMEL: Synthesis of epothilones A and B in solid and solution phase. Nature 387: 268-272, 1997
10. GUERITTE-VOEGELEIN, F.; D. GUENARD, F. LAVELLE, M. T. LEGOFF, L. MANGATAL & P. POTIER: Relationships between the structure of taxol analogues and their antimitotic activity. J. Med. Chem. 34: 992-998, 1991
11. KATO, Y.; Y. OGAWA, T. IMADA, S. IWASAKI, N. SHIMAZAKI, T. KOBAYASHI & T. KOMAI: Studies on macrocyclic lactone antibiotics. XIII. Anti-tubulin activity and cytotoxicity of rhizoxin derivatives: synthesis of a photoaffinity derivative. J. Antibiotics 44: 66-75, 1991
12. CUI, C.-B.; H. KAKEYA, G. OKADA, R. ONOSE, M. UBUKATA, I. TAKAHASHI, K. ISONO & H. OSADA: Tryprostatins A and B, novel mammalian cell cycle inhibitors produced by Aspergillus fumigatus. J. Antibiotics 48: 1382-1384, 1995
13. USUI, T.; M. KONDOH, C.-B. CUI, T. MAYUMI & H. OSADA: Tryprostatin A, a specific and novel inhibitor of microtubule assembly inhibitor. Biochem. J. 333: 543-548, 1998
14. CUI, C.-B.; H. KAKEYA & H. OSADA: Novel mammalian cell cycle inhibitors, spirotryprostatins A and B, produced by Aspergillus fumigatus, which inhibit mammalian cell cycle at G2/M phase. Tetrahedron 52: 12651-12666, 1996
15. CUI, C.-B.; H. KAKEYA & H. OSADA: Novel mammalian cell cycle inhibitors, cyclotryprostatins A ∼ D, produced by Aspergillus fumigatus, which inhibit mammalian cell cycle at G2/M phase. Tetrahedron 53: 59-72, 1997
16. OSADA, H.; C.-B. CUI, R. ONOSE & F. HANAOKA: Screening of cell cycle inhibitors from microbial metabolites by a bioassay using a mouse cdc2 mutant cell line, tsFT210. Bioorg. Med. Chem. 5: 193-203, 1997